ArticleTranslational vision science & technology2022
Early Diagnosis and Quantitative Analysis of Stages in Retinopathy of Prematurity Based on Deep Convolutional Neural Networks.
Article in Translational vision science & technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 23 citations in OpenAlex.
- Review
- VEA-net: vascular enhancement attention with dual-backbone multi-task learning for comprehensive ROP management across multi-center datasets.Frontiers in cell and developmental biology · 2026Article
- FARFUM-RoP, A dataset for computer-aided detection of Retinopathy of Prematurity.Scientific data · 2024Article
- Automated detection of type 1 ROP, type 2 ROP and A-ROP based on deep learning.Eye (London, England) · 2024Article
- An Interpretable System for Screening the Severity Level of Retinopathy in Premature Infants Using Deep Learning.Bioengineering (Basel, Switzerland) · 2024Article
- Automatic zoning for retinopathy of prematurity with a key area location system.Biomedical optics express · 2024Article
- Transforming the future of ophthalmology: artificial intelligence and robotics' breakthrough role in surgical and medical retina advances: a mini review.Frontiers in medicine · 2024Review
- Fairness and generalisability in deep learning of retinopathy of prematurity screening algorithms: a literature review.BMJ open ophthalmology · 2023Review
- GabROP: Gabor Wavelets-Based CAD for Retinopathy of Prematurity Diagnosis via Convolutional Neural Networks.Diagnostics (Basel, Switzerland) · 2023Article
- Research progress on diagnosing retinal vascular diseases based on artificial intelligence and fundus images.Frontiers in cell and developmental biology · 2023Review
- Association of Optical Coherence Tomography-Measured Fibrovascular Ridge Thickness and Clinical Disease Stage in Retinopathy of Prematurity.JAMA ophthalmology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Retinopathy of prematurity (ROP) is a leading cause of childhood blindness. An accurate and timely diagnosis of the early stages of ROP allows ophthalmologists to recommend appropriate treatment while blindness is still preventable. The purpose of this study was to develop an automatic deep convolutional neural network-based system that provided a diagnosis of stage I to III ROP with feature parameters. Methods: We developed three data sets containing 18,827 retinal images of preterm infants. These retinal images were obtained from the ophthalmology department of Jiaxing Maternal and Child Health Hospital in China. After segmenting images, we calculated the region of interest (ROI). We trained our system based on segmented ROI images from the training data set, tested the performance of the classifier on the test data set, and evaluated the widths of the demarcation lines or ridges extracted by the system, as well as the ratios of vascular proliferation within the ROI on a comparison data set. Results: The trained network achieved a sensitivity of 90.21% with 97.67% specificity for the diagnosis of stage I ROP, 92.75% sensitivity with 98.74% specificity for stage II ROP, and 91.84% sensitivity with 99.29% sensitivity for stage III ROP. When the system diagnosed normal images, the sensitivity and specificity reached 95.93% and 96.41%, respectively. The widths (in pixels) of the demarcation lines or ridges for normal, stage I, stage II, and stage III were 15.22 ± 1.06, 26.35 ± 1.36, and 30.75 ± 1.55. The ratios of the vascular proliferation within the ROI were 1.40 ± 0.29, 1.54 ± 0.26, and 1.81 ± 0.33. All parameters were statistically different among the groups. When physicians integrated quantitative parameters of the extracted features with their clinic diagnosis, the κ score was significantly improved. Conclusions: Our system achieved a high accuracy of diagnosis for stage I to III ROP. It used the quantitative analysis of the extracted features to assist physicians in providing classification decisions. Translational Relevance: The high performance of the system suggests potential applications in ancillary diagnosis of the early stages of ROP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.